Use of Chromogenic Substrate S-2251 for Determination of Plasminogen Activator in Rat Ovaries

Summary

A simple, specific and reproducible method for determination of plasminogen activator activity in rat ovaries has been developed by using the chromogenic substrate S-2251. The two steps of enzymatic reactions, i. e. activation of plasminogen and subsequent hydrolysis of the substrate was performed in one step incubation. A linear relationship was observed between the amount of chromogen produced and activator activity in the range of the optical density from 0.05 to 1.20 for 30 min’s incubation. Endogenous activity of non-specific proteases, plasmin or plasmin inhibitors which might be contained in rat ovaries turned out not to interfere with the specificity of a standardized assay procedure. Reproducibility was firmly established with coefficient of variation not exceeding 10%. Using this method, a marked increase followed by a drastic decrease in the activator activity was shown with rat ovaries around the time of ovulation after the injection of human chorionic gonadotropin.

Keywords

Plasminogen activator - Plasmin - Ovulation - S-2251

• References

• 1 Friberger P, Knös M, Gustavsson S, Aurell L, Claeson G. Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis 1978; 7: 138-145
• 2 Naito K, Aoki N. Assay of α₂-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate. Thromb Res 1976; 12: 1147-1156
• 3 Latallo ZS, Teisseyre E, Lopaciuk S. Assessment of plasma fibrinolytic system with use of chromogenic substrate. Haemostasis 1978; 7: 150-154
• 4 Takada A, Urano T, Takada Y. Influence of coagulation on the activation of plasminogen by streptokinase and urokinase. Thromb Haemostas 1979; 42: 901-908
• 5 Beers WH. Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall. Cell 1975; 6: 379-386
• 6 Strickland S, Beers WH. Studies on the role of plasminogen activator in ovulation. J Biol Chem 1976; 251: 5694-5702
• 7 Unkeless JC, Tobia A, Ossowski L, Quigley JP, Rifkin DB, Reich E. An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. Chick embryo fibroblast cultures transformed by Avian RNA and tumor viruses. J Exp Med 1973; 137: 85-111
• 8 Soria J, Soria C, Samma M. Dosage du plasminogène à I’aide d’un substrat chromogène tripeptidique. Pathologie Biologie 1976; 24: 725-729
• 9 Ohki Y, Matsuno T, Kondo S, Gojo N, Hara Y, Matsuo O, Iwasaki T. An automated assay of plasmin in euglobulin fraction with chromogenic substrate S-2251. Jap J Clin Path 1980; 12: 1247-1251
• 10 Mori T, Suzuki A, Nishimura T, Kambegawa A. Inhibition of ovulation in immature rats by anti-progesterone antiserum. J Endocr 1977; 73: 185-186
• 11 Edy J, de Cock F, Collen D. Inhibition of plasmin by normal and antiplasmin depleted plasma. Thromb Res 1976; 8: 513-518
• 12 Moroi M, Aoki N. Isolation and characterization of α₂-plasmin inhibitor from human plasma. J Biol Chem 1976; 251: 5956-5965
• 13 Beers WH, Strickland S, Reich E. Ovarian plasminogen activator: Relationship to ovulation and hormonal regulation. Cell 1975; 6: 387-394
• 14 Ossowski L, Unkeless JC, Tobia A, Quigley JP, Rifkin DB, Reich E. An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammarian fibroblast cultures transformed by DNA and RNA tumor viruses. J Exp Med 1973; 137: 112-126
• 15 Vassalli JD, Hamilton J, Reich E. Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors and cyclic nucleotides. Cell 1976; 8: 271-281
• 16 Unkeless JC, Gordon S, Reich E. Secretion of plasminogen activator by stimulated macrophages. J Exp Med 1974; 139: 834-850
• 17 Strickland S, Reich E. Plasminogen activator in eary embryogenesis: enzyme production by trophoblast and partial endoderm. Cell 1976; 9: 231-240